India Hosts World's Second-Largest Diabetes Population in 2024, Lancet Study

Written By :  Anshika Mishra
Published On 2026-01-17 12:30 GMT   |   Update On 2026-01-17 12:30 GMT
Advertisement

India tops global diabetes charts with 90 million adults affected in 2024, second only to China's 148 million, as per the latest IDF Diabetes Atlas in The Lancet Diabetes & Endocrinology—projecting a worldwide surge to 853 million by 2050. The eleventh edition, from IDF Belgium, India Diabetes Research Foundation, and Dr. A. Ramachandran's Chennai hospital, analyzed 246 studies across 215 countries from 2005-2024. One in nine adults (589 million aged 20-79) now lives with diabetes, peaking at 25% in the 75-79 age group. Men face higher rates than women, urban dwellers more than rural. China leads (148M), followed by India (90M), US (39M), with Pakistan eyeing third spot by 2050.

Advertisement

Low- and middle-income countries bear 80.64% of cases, poised for 95% of future rises due to population growth, ageing, and urbanization. Middle-income nations show highest prevalence (11.46%), then high-income (10.21%) and low-income (7.47%), as reported by NDTV.

Experts urge robust data collection in resource-poor areas and tailored strategies to curb the unchecked epidemic since 2000. "Stronger efforts are needed to slow progression across countries and groups," they warn, emphasizing prevention amid escalating burdens.

Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News